Acute high-risk pulmonary embolism requiring thrombolytic therapy in a COVID-19 pneumonia patient despite intermediate dosing deep vein thromboprophylaxis

Cytokine storm induced by the coronavirus 19 (COVID-19) profoundly activates the coagulation cascade causing venous thromboembolism (VTE). Initial studies from Wuhan, China showed increased incidence of VTE in patients with no standard deep vein thrombosis (DVT) prophylaxis in COVID-19 pneumonia pat...

Full description

Autores:

Tipo de recurso:

Article of investigation

Fecha de publicación:

2020

Institución:

Universidad de Bogotá Jorge Tadeo Lozano

Repositorio:

Expeditio: repositorio UTadeo

Idioma:

eng

OAI Identifier:

oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/14598

Acceso en línea:

https://doi.org/10.1016/j.rmcr.2020.101263
http://hdl.handle.net/20.500.12010/14598

Palabra clave:

Pulmonary embolism
COVID-19
Thrombolytic therapy
DVT prophylaxis
Venous thromboembolism
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus

Rights

License

Abierto (Texto Completo)